Cite

HARVARD Citation

    Luong, V. et al. (n.d.). Anti-CX3CL1 monoclonal antibody: A promising therapy for systemic sclerosis. Journal of dermatological science. 84 (1), pp. e111-e112. [Online]. 
  
Back to record